Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 114Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Recurrence 17Burkitt Lymphoma 14Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 6Lymphoma 6Leukemia, Biphenotypic, Acute 5Immunoglobulin Light-chain Amyloidosis 5Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell 4Waldenstrom Macroglobulinemia 3Neoplasm Metastasis 3Nausea 3Lung Neoplasms 3Leukemia 3Smoldering Multiple Myeloma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Paraproteinemias 2Ovarian Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Down Syndrome 2

Interventions

ponatinib 4Methotrexate 4Cytarabine 4Cyclophosphamide 4merphos 3Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3venetoclax 2fludarabine phosphate 2Tacrolimus 2Idarubicin 2Etoposide 2Cyclosporine 2Cladribine 2Busulfan 2prednylidene 1nilotinib 1midostaurin 1gilteritinib 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1bosutinib 1blinatumomab 1auricularum 1asciminib 1Vincristine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blast Crisis × Dexamethasone × 90 days × Clear all
NCT01424982 2026-04-15

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
88 enrolled
LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡